The Department of Biomedical Sciences manages the research activity in Biology, Medicine and Public Health. It provides technologies and services to both the public and the private area, with the purpose of promoting knowledge on the fundamental mechanism governing physiological and pathological aspects in living organism, starting from basic research in life sciences to the study of human diseases and of innovative therapeutic interventions. The ultimate aim is to explore new opportunities for ameliorating the health of mankind.
The fundamental activities regard oncology, neurodegenerative diseases, cardiovascular and pulmonary diseases, immunology and infectious diseases, epidemiology and health care research, Biology and biomedical technologies. In these areas, some technologies have been developed and they have found a wider use in the different benchmark areas: proteomics, pharmacogenomics, advanced calculus in bioinformatics and system biology, robotic systems for the limbs’ rehabilitation, molecular diagnostics and imaging.
The World Health Organization has designated the Neuroscience Institute as a WHO Collaborating Centre
The World Health Organization (WHO) has designated the Cnr Institute of Neuroscience (Cnr-In) as a WHO Collaborating Center for 'Longitudinal Health and Cross-Country Statistical modelling' and Nadia Minicuci (Cnr-In) will act as Head of the Centre.
On the first of January 2019, the European project SensApp (Super-sensitive detection of Alzheimer's disease biomarkers in plasma by an innovative droplet and split-stack approach) officially started, with the aim of developing a super-sensor for the early diagnosis of the Alzheimer's disease by a simple blood test
Teodoro Pulvirenti, executive editor of the Journal of Experimental Medicine (Jem), Rockefeller University Press, New York, USA, will give a Seminar on 'Scientific publishing: what, hw and why?'. During this seminar, Teodoro Pulvirenti will discuss the different steps involved in scientific publishing and provide guidance on how to prepare your manuscripts and rebuttals for maximal impact. He will discuss cover letters, rebuttals, and press releases, among other content, how prepared to talk about research and learn effective means of discussing science
Endocrine disruptors (EDs) are a class of chemicals used to produce materials commonly found in everyday life, such as some plastics, tin cans, electrical and household appliances, cosmetics, pesticides, etc. EDs are, however, not without danger: these molecules interfere with the endocrine system, disrupting the physiological production and the target effects of hormones. In particular, EDs have proven effects on the reproductive system and an incidence on the occurrence of obesity, type 2 diabetes and cardiovascular diseases during aging. The new European collaborative project SCREENED aims to develop new 3D in vitro tests to overcome these limitations
AI4H:B²E 2019 - IEEE International Special Track on Artificial Intelligence for Healthcare: from black box to explainable models
The special track on “Artificial Intelligence for Healthcare: from black box to explainable models” - AI4H:B2E 2019 - aims at bringing together researchers from academia, industry, government and medical centers in order to present the state of the art and discuss the latest advances in the emerging area of the use of Artificial Intelligence (AI) and Soft Computing (SC) techniques in the fields of medicine, biology, healthcare and wellbeing
Cnr-Isa is amongst the research partners of 'Stance4Health', a project funded by European Union’s Horizon 2020 with tha aim of developing a complete Smart Personalized Nutrition (SPN) service based on the use of mobile technologies as well as tailored food production that will optimize the gut microbiota activity and long-term consumer engagement
The use of risk of becoming dependent on other drugs does not depend on the type of cigarette (conventional or electronic) but on the nicotine they contain because both increase the gratification induced by Δ9-tetrahydrocannabinol (THC), the active ingredient of marijuana, and therefore facilitate its use. This is the finding of a study by the National Research Council’s Institute of Neurosciences published in European Neuropsychopharmacology that provides important suggestions concerning the molecular mechanisms underlying this effect